RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/SHA-384/9AAC6CC2F98CFCF0F01A6AD67255A42766915A28F3AE3921AD41F6BA0EA47EC22D6F133963C1E0CAD9B9FF85BB800B5Bhttp://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/9AAC6CC2F98CFCF0F01A6AD67255A42766915A28F3AE3921AD41F6BA0EA47EC22D6F133963C1E0CAD9B9FF85BB800B5Bhttp://www.w3.org/2000/01/rdf-schema#comment"In addition 6 other cancer-associated genes (BRAF NRAS HRAS ERK1 ERK2 and PTEN) were also analyzed. In total four somatic mutations were identified in three out of 101 ovarian endometriotic lesions (4% 4/101) including a KRAS p.G12V a PPP2R1A p.S256F and two ARID1A nonsense mutations (p.Q403* and p.G1926*); while no mutations were identified in the remaining 7 genes (BRAF NRAS HRAS ERK1 ERK2 PTEN and PIK3CA)"xsd:string
http://purl.uniprot.org/uniprot/#_EA5B81C854EBD00B64A5AD39E3F846A55CE029CB7E6EE52FF43129C6AC82441B7A7DB4DE33D6AE6AFB91E30BFF95B752http://www.w3.org/1999/02/22-rdf-syntax-ns#subjecthttp://purl.uniprot.org/SHA-384/9AAC6CC2F98CFCF0F01A6AD67255A42766915A28F3AE3921AD41F6BA0EA47EC22D6F133963C1E0CAD9B9FF85BB800B5B
http://purl.uniprot.org/uniprot/B3KQV6http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/9AAC6CC2F98CFCF0F01A6AD67255A42766915A28F3AE3921AD41F6BA0EA47EC22D6F133963C1E0CAD9B9FF85BB800B5B
http://purl.uniprot.org/uniprot/#_B3KQV6-mappedCitation-29547736http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/9AAC6CC2F98CFCF0F01A6AD67255A42766915A28F3AE3921AD41F6BA0EA47EC22D6F133963C1E0CAD9B9FF85BB800B5B